These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Testosterone therapy in women: a review. Bolour S; Braunstein G Int J Impot Res; 2005; 17(5):399-408. PubMed ID: 15889125 [TBL] [Abstract][Full Text] [Related]
28. Decline of serum levels of free testosterone in aging healthy Chinese men. Li JY; Li XY; Li M; Zhang GK; Ma FL; Liu ZM; Zhang NY; Meng P Aging Male; 2005; 8(3-4):203-6. PubMed ID: 16390747 [TBL] [Abstract][Full Text] [Related]
29. The male climacteric. Schirren C Nihon Funin Gakkai Zasshi; 1976 Apr; 21(2):207-13. PubMed ID: 1033867 [No Abstract] [Full Text] [Related]
30. Validation of a screening questionnaire for androgen deficiency in aging males. Morley JE; Charlton E; Patrick P; Kaiser FE; Cadeau P; McCready D; Perry HM Metabolism; 2000 Sep; 49(9):1239-42. PubMed ID: 11016912 [TBL] [Abstract][Full Text] [Related]
31. Defining 'relative' androgen deficiency in aging men: how should testosterone be measured and what are the relationships between androgen levels and physical, sexual and emotional health? Haren MT; Morley JE; Chapman IM; O'Loughlin PD; Wittert GA Climacteric; 2002 Mar; 5(1):15-25. PubMed ID: 11974555 [TBL] [Abstract][Full Text] [Related]
32. [Sexuality changes in a hemodialysis patient with hyperprolactinemia: therapeutic possibilities]. Mondaini F; Gavazzi M; Benelli R; De Maio P Riv Ital Ginecol; 1980; 59 Suppl():93-6. PubMed ID: 6813937 [No Abstract] [Full Text] [Related]
33. The effect of sexual hormone abnormalities on proximal femur bone mineral density in hemodialysis patients and the possible role of RANKL. Doumouchtsis KK; Kostakis AI; Doumouchtsis SK; Grapsa EI; Passalidou IA; Tziamalis MP; Poulakou MV; Vlachos IS; Perrea DN Hemodial Int; 2008 Jan; 12(1):100-7. PubMed ID: 18271850 [TBL] [Abstract][Full Text] [Related]
34. Hormones and sexuality: current complexities and future directions. Basson R Maturitas; 2007 May; 57(1):66-70. PubMed ID: 17367966 [TBL] [Abstract][Full Text] [Related]
35. Androgen deficiency symptoms in testicular cancer survivors are associated with sexual problems but not with serum testosterone or therapy. Lackner JE; Koller A; Schatzl G; Marberger M; Kratzik C Urology; 2009 Oct; 74(4):825-9. PubMed ID: 19589582 [TBL] [Abstract][Full Text] [Related]
36. [Estrogen and gonadotropin values in physiological and artificial postmenopause]. Rezaković-Musić D Lijec Vjesn; 1981 Jul; 103(7):288-92. PubMed ID: 6801409 [No Abstract] [Full Text] [Related]
37. [Changes in sexual activity and serum hormone concentrations in male patients with Graves' disease]. Luo GC; Li JY; Guo AY Zhonghua Nei Ke Za Zhi; 1987 Sep; 26(9):520-2, 564. PubMed ID: 3450471 [No Abstract] [Full Text] [Related]
38. [Neuroendocrinology of male climacteric]. Frajese G; Jannini EA; Moretti C G Clin Med; 1989 Dec; 70(12):767, 771, 773-80. PubMed ID: 2612807 [No Abstract] [Full Text] [Related]
39. [The male climacteric. A responsibility for dermatologic andrology?]. Krause W Hautarzt; 1994 Sep; 45(9):593-8. PubMed ID: 7960765 [TBL] [Abstract][Full Text] [Related]
40. Estrogen in treatment of the male climacteric. Rosenbaum MG Rocky Mt Med J; 1973 Sep; 70(9):37-8. PubMed ID: 4727692 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]